Pharmacokinetics of Three Gadolinium Chelates with Different Molecular Sizes Shortly After Intravenous Injection in Rabbits
- 1 April 2000
- journal article
- research article
- Published by Wolters Kluwer Health in Investigative Radiology
- Vol. 35 (4) , 213-218
- https://doi.org/10.1097/00004424-200004000-00001
Abstract
Corot C, Violas X, Robert P, Port M. Pharmacokinetics of three gadolinium chelates with different molecular sizes shortly after intravenous injection in rabbits: Relevance to MR angiography. Invest Radiol 2000;35:213–218. RATIONALE AND OBJECTIVES. To mimic an MR angiographic protocol, an experimental model was developed in rabbits to determine gadolinium concentrations in blood early after injection. Contrast agents with different molecular sizes were compared. METHODS. The influence of injection parameters (injection rate, duration of injection, volume of injection, dose) was assessed, and two blood pool agents (P760, P717) were compared with the low-molecular-weight Gd-DOTA under similar conditions. RESULTS. Two main phases were identified: bolus and postbolus. Injection parameters strongly influenced the pattern of the bolus phase, but the postbolus phase was sensitive only to the injected dose. The blood pool agents presented a bolus phase profile similar to that of Gd-DOTA, but 45 seconds after injection, 84% of P717 molecules were still present in the blood compartment, compared with 65% of P760 molecules and only 51% of Gd-DOTA molecules. CONCLUSIONS. Blood pool agents are useful for MR angiographic protocols involving the postbolus phase. In protocols in which only the bolus phase is imaged, blood pool agents provide similar data to Gd-DOTA, provided that the injection rate, iso-T1 efficiency dose, and volume are similar.Keywords
This publication has 10 references indexed in Scilit:
- Infarcted Myocardium in Pigs: MR Imaging Enhanced with Slow-Interstitial-Diffusion Gadolinium Compound P760Radiology, 1999
- P760 and P775: MRI contrast agents characterized by new pharmacokinetic propertiesMagnetic Resonance Materials in Physics, Biology and Medicine, 1999
- Equilibrium phase MR angiography of the aortic arch and abdominal vasculature with the blood pool contrast agent CMD-A2-Gd-DOTA in pigsJournal of Magnetic Resonance Imaging, 1999
- Renal Arteries: Optimization of Three-dimensional Gadolinium-enhanced MR Angiography with Bolus-timing-independent Fast Multiphase Acquisition in a Single Breath HoldRadiology, 1999
- Stepping-Table Gadolinium- enhanced Digital Subtraction MR Angiography of the Aorta and Lower Extremity Arteries: Preliminary ExperienceRadiology, 1999
- Scan optimization of gadolinium contrast-enhanced three-dimensional MRA of peripheral arteries with multiple bolus injections and in vitro validation of stenosis quantificationMagnetic Resonance Imaging, 1999
- Optimizing Three-Dimensional Gadolinium-Enhanced Magnetic Resonance AngiographyInvestigative Radiology, 1998
- Steady-state and dynamic MR angiography with MS-325: initial experience in humans.Radiology, 1998
- Contrast-enhanced abdominal MR angiography: optimization of imaging delay time by automating the detection of contrast material arrival in the aorta.Radiology, 1997
- Rationale and applications for macromolecular Gd‐based contrast agentsMagnetic Resonance in Medicine, 1991